@cbsnews: U.S. Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz says if Congress codifies the pharmaceutical deals put forward under the most-favored-nation drug pricing, "the National Economic Council estimates about $600 billion in savings over the next decade." Dr. Oz says he expects the pharmaceutical companies to go through with the deal "because as much as they've saved the American taxpayer money, Wall Street has rewarded these companies." "The market cap of pharmaceutical industry, in general, has gone up tens of billions of dollars, so it's stability they want," he adds.